43152-93-8

Basic information

• Product Name: 1-ETHYLPIPERIDIN-3-ONE
• Synonyms: 1-ETHYLPIPERIDIN-3-ONE;1-Ethyl-3-piperidinone;1-Ethyl-3-piperidone;N-Ethyl-3-piperidinone;N-Ethyl-3-piperidone
• CAS NO: 43152-93-8
• Molecular Formula: C₇H₁₃NO
• Molecular Weight: 127.18
• EINECS: 255-333-6
• Mol File: 43152-93-8.mol

Chemical Properties

• Boiling Point: 186.8 °C at 760 mmHg
• Flash Point: 61.6 °C
• Appearance: /
• Density: 0.966 g/cm³
• PKA: 7.13±0.20(Predicted)
• CAS DataBase Reference: 1-ETHYLPIPERIDIN-3-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-ETHYLPIPERIDIN-3-ONE(43152-93-8)
• EPA Substance Registry System: 1-ETHYLPIPERIDIN-3-ONE(43152-93-8)

Safety Data

• Hazardous Substances Data: 43152-93-8(Hazardous Substances Data)

Usage

Type of compound

Cyclic ketone

Usage

Building block in the synthesis of pharmaceuticals and agrochemicals

Physical state

Clear, colorless liquid

Odor

Distinct

Solubility

Soluble in organic solvents such as ethanol, ether, and chloroform

Applications

Intermediate in the production of various drugs, manufacturing of other organic compounds, fragrance and flavor industry

Safety precautions

Harmful if ingested or inhaled, may cause skin and eye irritation, should be handled with caution

Upstream product

• 757976-73-1 4-(ethoxycarbonylmethyl-ethyl-amino)-butyric acid ethyl ester 
• 41361-28-8 1-ethyl-3-piperidone hydrochloride 

Downstream Products

• 100861-52-7 (1-ethyl-[3]piperidyl)-benzyl-amine 
• 13444-24-1 1-ethyl-3-hydroxypiperidine 
• 155652-25-8 1-ethyl-3-<(phenylthio)methyl>piperidin-3-ol 
• 182345-24-0 4-(2,2-Dimethoxy-ethyl)-3-(1-ethyl-piperidin-3-ylamino)-benzoic acid methyl ester 
• 155652-26-9 1-ethyl-3-<(phenylthio)methyl>-1,2,5,6-tetrahydropyridine 
• 562839-74-1 4-Benzhydryl-1-ethyl-3-piperidinone 
• 1023277-55-5 3-(3-aminophenyl)-1-ethylpiperidin-3-ol 
• 1220038-66-3 C₉H₁₇NO₂ 

Relevant articles and documents

Lightening Agents and/or Dyes that Contain Aldehyde(s)

Agents for dyeing and/or lightening keratin fibers, in particular human hair, containing, relative to the weight thereof, 0.001 to 15 wt. % of at least one aldehyde of the formula (I): wherein X represents —CH(R2)—SO2—Y—R1, —CR3R4R5, or wherein Y represents —CH(CHO)— or —CH2— or a chemical bond, and wherein each of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 independently represents —H or —CN or —F or —Cl or —Br or —I or —CHO or —NH2 or —NO2 or —CF3 or —CCl3 or —CF2CF3 or —CCl2CCl3 or an optionally substituted (C1-C6) alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C1-C6) alkylene group, and wherein the agent contains no oxidation dye precursors of developer and coupler type.

Pyrid-2-one derivatives and methods of use

Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stroke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

NITROGENOUS CYCLIC KETONE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE

A novel compound represented by the formula (I): wherein rings A and B each represents an optionally substituted aromatic ring, or rings A and B may be bonded to each other through linking between bonds or substituents thereof to form a ring; ring C represents a nitrogenous saturated heterocycle optionally having one or more substituents besides the oxo (provided that 2,3-dioxopyrrolidine ring is excluded); R1 represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group; and-------- indicates a single bond or a double bond. It has high antagonistic activity against a tachykinin receptor, especially an SP receptor.